Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Insulin for Type 3c Diabetes in Pancreatic Cancer
NCT05306028Phase 2Active, not recruiting
- Sponsor
- Fudan University
- Start
- Aug 2022
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs), human insulin in type 3c diabetes mellitus (T3c), sponsored by Fudan University. Started Aug 2022; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)human insulin
03
Conditions
type 3c diabetes mellitus (T3c)
Beyond the preview
Go deeper on NCT05306028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306028.